Ucb Biopharma Srl
Clinical trials sponsored by Ucb Biopharma Srl, explained in plain language.
-
New drug shows promise for Long-Term control of rare eye muscle disease
Disease control Not yet recruitingThis study is for adults with ocular myasthenia gravis, a condition that causes muscle weakness in the eyes. Researchers want to see if the drug rozanolixizumab is safe and works well over a long period. About 100 people who have already taken the drug in a previous study will jo…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 17, 2026 08:16 UTC
-
New drug trial offers hope for rare eye muscle disease
Disease control Not yet recruitingThis study tests an investigational drug called rozanolixizumab against a placebo in 120 adults with ocular myasthenia gravis, a condition causing droopy eyelids and double vision. The main goal is to see if the drug reduces eye muscle weakness over 43 days. Participants must hav…
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 17, 2026 08:04 UTC